DOCSLIB.ORG

Malaria Consortium

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Malaria Consortium Malaria Consortium 2003-2013: a decade in communicable disease control and child health Contents 1 Chair’s foreword 2 Our birth and growth 6 Malaria Consortium, 2003-2013 8 Our evolution at country level 14 Disease control: malaria and neglected tropical diseases 22 Linking the community to health systems 30 Moving to elimination 38 Going forward Thank you The last 10 years for Malaria Consortium have been made possible thanks to the unwavering support of our donors, partners and collaborators from across the world. Collaboration and cooperation with others has been the cornerstone of all our achievements in the fight against malaria and other communicable childhood and neglected tropical diseases. It is thanks to these partnerships that we are able to provide some of the world’s most vulnerable people with better health care and offer them a chance for a future free from the burden of diseases which are treatable and preventable. t A key focus of Malaria Consortium has been effective diagnosis of malaria which helps save millions of lives Tadej Znidarcic Tadej Growing through innovation and partnership Malaria Consortium was founded by a small team of people with a vision – to build the capacity of malaria-endemic countries worldwide to deal with a common and treatable disease that was devastating the lives of poor and vulnerable communities. Over the course of a decade of innovation and Whilst the organisation has grown significantly, our strong partnerships, this vision has grown from focus on the national and grassroots level has enabled focusing solely on malaria control and prevention, us to remain an effective on-the-ground partner, which to include integrated approaches to improving child has meant that in all that we have done, we have health and neglected tropical diseases. Now working continued to build capacity in the countries where across Africa and Asia, we are delighted to take the we work. Dr Julian Lob-Levyt opportunity of our anniversary to reflect on what We remain as committed as our early pioneers Chair we have achieved. in ensuring that we continue to fight malaria, For the last 10 years, the global fight against malaria a disease that is both preventable and curable. has seen an incredible acceleration. Since 2000, global Looking forward, we will continue to grow as an prevention and control efforts have led to a significant organisation but with a renewed focus on developing decline in mortality rates across all ages, but especially integrated strategies that address malaria and other in children worldwide. For the first time, the goal of communicable diseases beyond 2015. These strategies elimination is starting to look achievable in a number will need continued investment, more effective of countries in Africa, an aspiration that would have treatments and new tools to maintain the progress “For the first time, the goal of been dismissed as unrealistic a decade ago. that has been made. elimination is starting to look Today, Malaria Consortium partners with ministries We would like to extend a huge thank you to achievable in a number of of health in 15 countries to combat disease and our partners and supporters who have worked countries in Africa, an aspiration improve child health. We work in six of the 25 highest alongside us for the last 10 years. It is because of malaria burden countries in the world, in post-conflict these partnerships that we are able to continue the that would have been dismissed countries and in areas of Southeast Asia where drug fight against malaria and other infectious diseases, as unrealistic a decade ago” resistance is a developing threat. providing communities worldwide with the support they need to have a future free from disease. Finally, and on behalf of the board, I would like to personally thank the staff and leadership of Malaria Consortium – both past and present. Without their dedication and professionalism, we would not be the respected and effective organisation that we have become. 1 Malaria Consortium: our birth and growth Dr Sylvia Meek Technical director t Malaria Consortium’s first organisational strategy meeting in 2004, including its founders Sunil Mehra (front row, third from right), Graham Root (middle row, centre) and Sylvia Meek (middle row, second from right) 2 Malaria Consortium: our birth and growth 2003-04 £0.9 million 2004-05 £1.2 million 2005-06 £3.2 million 2006-07 £5.4 million 2007-08 £10.2 million 2008-09 £12.5 million 2009-10 £19.0 million 2010-11 £24.6 million 2011-12 £30.4 million 2012-13 £31.2 million 2003-04 £0.9 million 2004-05 £1.2 million 2005-06 £3.2 million 2006-07 £5.4 million 2007-08 £10.2 million 2008-09 £12.5 million 2009-10 £19.0 million 2010-11 £24.6 million 2011-12 £30.4 million 2012-13 £31.2 million 2003-04 £0.9 million 2004-05 £1.2 million 2005-06 £3.2 million 2006-07 £5.4 million 2007-08 £10.2 million 2008-09 £12.5 million 2009-10 £19.0 million 2010-11 £24.6 million 2011-12 £30.4 million 2012-13 £31.2 million p Our income growth over the last decade 2003-04 £0.9 million 2004-05 £1.2 million 2005-06 £3.2 million 2006-07 £5.4 million 2007-08 £10.2 million 2008-09 £12.5 million 2009-10 £19.0 million 2010-11 £24.6 million 2011-12 £30.4 million 2012-13 £31.2 million such as the competition between investing in malaria malaria in investing between competition the as such debates, over-theoretical sometimes the at impatience some felt We found. had we gap a fill to but doing, were others what duplicated that organisation an up start to want not did We programmes. control malaria comprehensive shape to approaches new out trying available, resources the with more do to ministries with work to wanted We countries. endemic in capacity local building and programmes country from directly learning implementation, control malaria on more focus to wanted also we but strategy, and policy on advising consortium, original the of work the continue to wanted only not We born. was NGO the Consortium Malaria when is that and centre, resource health general a to on move to decided DFID years, nine After ones. existing evaluating and programmes new designing investment, control malaria on DFID advising on focused predominantly It (DFID). Development International for Department UK’s the for control malaria on centre resource a run to Medicine Tropical of School Liverpool the and Medicine Tropical & Hygiene of School London the between collaboration a was which Consortium, Malaria called also project, previous a in involved been had us of three The director. technical as myself and director Africa our as Root Graham director, executive first our as Mehra Sunil of leadership the under 2004 in launch official our with 2003 September in (NGO) organisation non-government a as started We 1960s. the of attempts eradication global failed the to backlash the by suppressed still was control whose disease, neglected extremely an was malaria when 1990s early the of out grew Consortium Malaria acceleration. sub-SaharanAfricaandAsiahasseenaremarkable diseases across For overadecadetheglobalfightagainstmalariaandotherinfectious 10The years first 10.666667 14.222222 17.777778 21.333333 24.888889 28.444444 32.000000 0.000000 3.555556 7.111111 in young children. children. young in pneumonia and diarrhoea with malaria of (ICCM) on work our with area, this in activities our expanded have we years four past the over and malaria on work our into health child incorporate to keen also were We private. and public community, and facility implementation, and research between points these bridge to aimed we and meet, elements two where are systems many in points weakest The delivery. service improving and testing continuously and practical staying of importance the saw We purpose. a serve to have systems the and systems, health strong needs control Malaria strengthening. systems health versus control successes over the the over successes significant some achieved has Consortium Malaria control. malaria with synergies the given focus, additional an become similarly learning through project materials and publications. and materials project through learning are we what better communicate to ability our been has highlight Another area. the in elimination malaria for stage the set to helping and resistance artemisinin eliminating of challenge urgent the supporting are which Asia in up set been have that systems information practical the seeing impressed extremely been also have I effect. great with and confidently environment complex a such in work their performing were literacy, low have whom of many country, the in trained have we that workers health community how see to encouraging was It Sudan. South in run to continue we that programmes ICCM the visiting was highlight Another Nigeria. in organised team our that distribution net mass first the by inspired particularly was I publication. this in highlights the of number a integrated community case management case community integrated past decade past Neglected tropical diseases tropical Neglected and you can read about about read can you and have have 3 At the centre of all our work has been partnership and The organisation has a strong culture of debate, and collaboration. We have played a key role in setting encouraging staff to express ideas has meant that u In Nigeria, we have helped up and supporting the global Roll Back Malaria programmes have been developed to the highest build demand for malaria Partnership (RBM). Our executive director at that standard. The Programme Partnership Arrangement related health services through training, support and behaviour time was the NGO representative on the RBM Board, with DFID over the past three years has helped to change communications.
Load more

Recommended publications
  • Cost-Effectiveness of District-Wide Seasonal
    Diawara et al. Malar J (2021) 20:128 https://doi.org/10.1186/s12936-021-03653-x Malaria Journal RESEARCH Open Access Cost-efectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fxed point distribution Halimatou Diawara1* , Patrick Walker2, Matt Cairns3, Laura C. Steinhardt4, Fatou Diawara1, Beh Kamate5, Laeticia Duval2, Elisa Sicuri2, Issaka Sagara1, Aboubacar Sadou6, Jules Mihigo7, Erin Eckert8, Alassane Dicko1 and Lesong Conteh9 Abstract Background: Seasonal malaria chemoprevention (SMC) is a strategy for malaria control recommended by the World Health Organization (WHO) since 2012 for Sahelian countries. The Mali National Malaria Control Programme adopted a plan for pilot implementation and nationwide scale-up by 2016. Given that SMC is a relatively new approach, there is an urgent need to assess the costs and cost efectiveness of SMC when implemented through the routine health system to inform decisions on resource allocation. Methods: Cost data were collected from pilot implementation of SMC in Kita district, which targeted 77,497 children aged 3–59 months. Starting in August 2014, SMC was delivered by fxed point distribution in villages with the frst dose observed each month. Treatment consisted of sulfadoxine-pyrimethamine and amodiaquine once a month for four consecutive months, or rounds. Economic and fnancial costs were collected from the provider perspective using an ingredients approach. Efectiveness estimates were based upon a published mathematical transmission model calibrated to local epidemiology, rainfall patterns and scale-up of interventions. Incremental cost efectiveness ratios were calculated for the cost per malaria episode averted, cost per disability adjusted life years (DALYs) averted, and cost per death averted.
    [Show full text]
  • Malaria History
    This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this site. Copyright 2006, The Johns Hopkins University and David Sullivan. All rights reserved. Use of these materials permitted only in accordance with license rights granted. Materials provided “AS IS”; no representations or warranties provided. User assumes all responsibility for use, and all liability related thereto, and must independently review all materials for accuracy and efficacy. May contain materials owned by others. User is responsible for obtaining permissions for use from third parties as needed. Malariology Overview History, Lifecycle, Epidemiology, Pathology, and Control David Sullivan, MD Malaria History • 2700 BCE: The Nei Ching (Chinese Canon of Medicine) discussed malaria symptoms and the relationship between fevers and enlarged spleens. • 1550 BCE: The Ebers Papyrus mentions fevers, rigors, splenomegaly, and oil from Balantines tree as mosquito repellent. • 6th century BCE: Cuneiform tablets mention deadly malaria-like fevers affecting Mesopotamia. • Hippocrates from studies in Egypt was first to make connection between nearness of stagnant bodies of water and occurrence of fevers in local population. • Romans also associated marshes with fever and pioneered efforts to drain swamps. • Italian: “aria cattiva” = bad air; “mal aria” = bad air. • French: “paludisme” = rooted in swamp. Cure Before Etiology: Mid 17th Century - Three Theories • PC Garnham relates that following: An earthquake caused destruction in Loxa in which many cinchona trees collapsed and fell into small lake or pond and water became very bitter as to be almost undrinkable. Yet an Indian so thirsty with a violent fever quenched his thirst with this cinchona bark contaminated water and was better in a day or two.
    [Show full text]
  • Malaria: Bad for Business Why Investing in Ending Malaria Provides Some of the Highest Economic Returns
    Malaria: Bad for business Why investing in ending malaria provides some of the highest economic returns. Malaria’s burden on the health and wealth of nations While huge progress has been made in recent years, one of the most striking signs of the global impact of the 215 million cases of malaria reported last year is that up to 40% of public health spending goes on the disease in the most heavily affected countries. But malaria reaches far beyond public health, taking its toll on households, local and multinational business profits, and national economic development. Critically, annual economic growth in countries with high malaria transmission has historically been lower than in countries without malaria. In some African countries, malaria reduces GDP growth up to an estimated 1.3%. Malaria costs productivity. Adults are forced to be absent from work, children miss school, and households spend disproportionately on health when they can least afford it. But it need not be this way. With developing countries, donors and private sector firms beginning to take real action, we can be the generation that ends malaria for good and boosts prosperity for all. The economic growth penalty Malaria’s impact on national economies Malaria and poverty occupy common ground. Where the burden of malaria is highest, economic prosperity is lowest. We know that poverty can promote malaria transmission, and that malaria causes poverty by blocking economic growth. Research shows that malaria can strain national economics, having a deleterious impact on some nations’ GDP by as much as an estimated 5 - 6%. It keeps households in poverty, discourages domestic and foreign investment and tourism, affects land use patterns, and reduces productivity through lost work days and diminished job performance.
    [Show full text]
  • OFTW's 2020 Annual Report
    August 2020 One for the World Annual Report [email protected] Executive Summary Introduction Current state of play | Performance | Lessons learnt | Outstanding questions Financial Metrics Donations in Year | Impact Snapshot | Recruitment | Donor Retention & Activation | Chapter Performance Our Growth FY20 & FY21 Financials | School Expansion | Our Partners Looking Ahead The Next Year | Lessons Learnt | Outstanding Questions | SWOT Analysis Our Charities Charity selection process | Our charities FY21 Strategy | July 2020 Dear Friends and Supporters Welcome to OFTW’s 2019/2020 annual report! I’m going to be honest - it’s a little hard to know what to say about this year. On the one hand, the world was turned upside down by coronavirus and our operating model was suddenly no longer viable. Then the Black Lives Matter protests brought home the searing consequences of social injustice in the US and elsewhere, and our passionate volunteers were understandably moved to get involved. One for the World HQ hasn’t met face-to-face since March and I was personally unable to move to the US as planned and now find myself in Berlin, waiting to see when American visas become available again. However, in amongst these extraordinary, unprecedented times, One for the World continues to offer thousands of genuinely heart-warming reminders that, together, we can revolutionize charitable giving to end extreme poverty. Our wonderful, passionate, relentless chapter leaders brought 750 new pledgers onboard in the Fall semester alone. Our inspiring members contributed $312k to the world’s most cost-effective charities (a 40% year-on-year increase). 42 new chapters started the setting up process during a global pandemic.
    [Show full text]
  • COVID-19 Surveillance Seminar - July 6, 2020
    COVID-19 Surveillance Seminar - July 6, 2020 Leveraging Systems for COVID-19 Surveillance Integrated Disease Surveillance and Response (IDSR), Malaria, and Polio Michelle Sloan, Division of Global Health Protection John Painter, Division of Parasitic Diseases and Malaria Wilbrod Mwanje, African Field Epidemiology Network (AFENET), Uganda cdc.gov coronavirus www.cdc.go /corona irus/2019-nco /global-co id-19 Integrated Disease Surveillance and Response (IDSR) . Integrates common sur eillance acti ities across diseases – Identify, Report, Analyze and Interpret, In estigate and Confirm, Prepare, Respond, Communicate, E aluate – Acti ities linked across community, district, and national le els of the health system . Reporting on country identified priority diseases (e.g. case based, aggregate) . Standardized data collection tools and data reporting to district le el . Thresholds defined for public health response . Impro ed data use through routine data analysis Incorporating COVID-19 into IDSR . Include COVID-19 on country priority disease list . De elop COVID-19 reporting tools – Indi idual case report, aggregate reporting form, contact tracing form . Train sur eillance focal points – Case identification using standard case definition – Immediate reporting of suspect cases . Case-based reporting of cases and deaths (aggregate if resources constrained) . Initiate response strategies based on threshold, for example – In estigation and contact tracing for each indi idual case – Population le el inter entions for clusters and outbreaks Leveraging Other IDSR Data . Monitor existing disease sur eillance for signals – Influenza – Malaria – Other fe er producing diseases . Indicators to analyze – Case and death counts – Trends – Geographical spread – Completeness – Timeliness Leveraging Other Disease Surveillance Strategies . Identify potential signals o erall or by region where there might be missed COVID-19 cases – Malaria sur eillance .
    [Show full text]
  • Strengthening Malaria Surveillance for Data- Driven Decision Making in Mozambique
    MALARIA CONSORTIUM PROJECT BRIEF Strengthening malaria surveillance for data- driven decision making in Mozambique Accelerating efforts to reduce the malaria burden by improving data quality and use across all transmission strata Background Country Mozambique Although Mozambique has made some progress in scaling up malaria control activities and aligning its malaria elimination efforts with neighbouring countries Donor Bill & Melinda Gates Foundation in southern Africa over the last decade, it remains the fourth largest contributor of malaria cases globally.[1] Length of project May 2019 – May 2022 To accelerate efforts to reduce the malaria burden, Mozambique urgently needs a fit-for-purpose surveillance system to provide the necessary intelligence to identify Partners bottlenecks in malaria control and elimination activities, target interventions more Clinton Health Access Initiative efficiently and respond when the impact of National Malaria Control Programme Goodbye Malaria/LSDI2 activities is jeopardised. Manhica Health Research Centre Ministry of Health A malaria surveillance system is considered functional and responsive when it World Health Organization can produce evidence-based information from quality data that is routinely used Collaborator for planning and decision making. The 2018 national malaria surveillance system U.S. President’s Malaria Initiative assessment identified the following main obstacles: • poor malaria data quality (DQ) and data use (DU) • lack of an integrated malaria information storage system (iMISS) •
    [Show full text]
  • Malaria and COVID-19: Common and Different Findings
    Tropical Medicine and Infectious Disease Viewpoint Malaria and COVID-19: Common and Different Findings Francesco Di Gennaro 1 , Claudia Marotta 1,*, Pietro Locantore 2, Damiano Pizzol 3 and Giovanni Putoto 1 1 Operational Research Unit, Doctors with Africa CUAMM, 35121 Padova, Italy; [email protected] (F.D.G.); [email protected] (G.P.) 2 Institute of Endocrinology, Università Cattolica del Sacro Cuore, 00168 Rome, Italy; [email protected] 3 Italian Agency for Development Cooperation, Khartoum 79371, Sudan; [email protected] * Correspondence: [email protected] or [email protected] Received: 31 July 2020; Accepted: 3 September 2020; Published: 6 September 2020 Abstract: Malaria and COVID-19 may have similar aspects and seem to have a strong potential for mutual influence. They have already caused millions of deaths, and the regions where malaria is endemic are at risk of further suffering from the consequences of COVID-19 due to mutual side effects, such as less access to treatment for patients with malaria due to the fear of access to healthcare centers leading to diagnostic delays and worse outcomes. Moreover, the similar and generic symptoms make it harder to achieve an immediate diagnosis. Healthcare systems and professionals will face a great challenge in the case of a COVID-19 and malaria syndemic. Here, we present an overview of common and different findings for both diseases with possible mutual influences of one on the other, especially in countries with limited resources. Keywords: malaria; SARS-CoV-2; COVID-19; preparedness; Africa; emergency; pandemic 1. Background On 11 March 2020, the WHO declared the outbreak of SARS-CoV-2 to be a pandemic infection.
    [Show full text]
  • The Columbian Exchange: a History of Disease, Food, and Ideas
    Journal of Economic Perspectives—Volume 24, Number 2—Spring 2010—Pages 163–188 The Columbian Exchange: A History of Disease, Food, and Ideas Nathan Nunn and Nancy Qian hhee CColumbianolumbian ExchangeExchange refersrefers toto thethe exchangeexchange ofof diseases,diseases, ideas,ideas, foodfood ccrops,rops, aandnd populationspopulations betweenbetween thethe NewNew WorldWorld andand thethe OldOld WWorldorld T ffollowingollowing thethe voyagevoyage ttoo tthehe AAmericasmericas bbyy ChristoChristo ppherher CColumbusolumbus inin 1492.1492. TThehe OldOld WWorld—byorld—by wwhichhich wwee mmeanean nnotot jjustust EEurope,urope, bbutut tthehe eentirentire EEasternastern HHemisphere—gainedemisphere—gained fromfrom tthehe CColumbianolumbian EExchangexchange iinn a nnumberumber ooff wways.ays. DDiscov-iscov- eeriesries ooff nnewew ssuppliesupplies ofof metalsmetals areare perhapsperhaps thethe bestbest kknown.nown. BButut thethe OldOld WWorldorld aalsolso ggainedained newnew staplestaple ccrops,rops, ssuchuch asas potatoes,potatoes, sweetsweet potatoes,potatoes, maize,maize, andand cassava.cassava. LessLess ccalorie-intensivealorie-intensive ffoods,oods, suchsuch asas tomatoes,tomatoes, chilichili peppers,peppers, cacao,cacao, peanuts,peanuts, andand pineap-pineap- pplesles wwereere aalsolso iintroduced,ntroduced, andand areare nownow culinaryculinary centerpiecescenterpieces inin manymany OldOld WorldWorld ccountries,ountries, namelynamely IItaly,taly, GGreece,reece, andand otherother MediterraneanMediterranean countriescountries (tomatoes),(tomatoes),
    [Show full text]
  • Diseases of Poverty and the 10/90 Gap Diseases of Poverty and the 10/90 Gap Diseases of Poverty and the 10/90 Gap
    Diseases of poverty and the 10/90 gap Diseases of poverty and the 10/90 Gap Diseases of poverty and the 10/90 Gap Written by Philip Stevens, Director of Health Projects, International Policy Network November 2004 International Policy Network Third Floor, Bedford Chambers The Piazza London WC2E 8HA UK t : +4420 7836 0750 f: +4420 7836 0756 e: [email protected] w : www.policynetwork.net © International Policy Network 2004 Designed and typeset in Latin 725 by MacGuru Ltd [email protected] Cover design by Sarah Hyndman Printed in Great Britain by Hanway Print Centre 102–106 Essex Road Islington N1 8LU All rights reserved. Without limiting the rights under copyright reserved above, no part of this publication may be reproduced, stored or introduced into a retrieval system, or transmitted, in any form or by any means (electronic, mechanical, photocopying, recording or otherwise) without the prior written permission of both the copyright owner and the publisher of this book. Diseases of poverty and the 10/90 Gap Introduction: What is the 10/90 Gap? Figure 1 Number of daily deaths from diseases7 Activists claim that only 10 per cent of global health research is devoted to conditions that account for 90 Respiratory 10,814 per cent of the global disease burden – the so-called infections 1 ‘10/90 Gap’. They argue that virtually all diseases HIV/ 7,852 AIDS prevalent in low income countries are ‘neglected’ Diarrhoeal 5,482 and that the pharmaceutical industry has invested diseases almost nothing in research and development (R&D) Tuberculosis 4,504 for these diseases.
    [Show full text]
  • UGANDA Who We Are
    UGANDA WHO WE ARE The principal aim of The organisation works to monitoring and evaluation Malaria Consortium is the improve not only the health and operational research. of the individual, but also the Since then, the Malaria Consortium prevention and treatment of capacity of national health disease, particularly but not Uganda programme has expanded systems and communities, its focus to include tuberculosis, exclusively malaria, among which contributes towards pneumonia, diarrhoea and the poorest and most at risk. poverty relief and improved neglected tropical diseases. Malaria Consortium works economic prosperity. Cross cutting aspects such as in a variety of settings Malaria Consortium started health system strengthening, accross Africa and Asia, its Uganda programme in 2003 private sector support, maternal to provide technical assistance and child health are also becoming using innovative strategies to the Ministry of Health (MoH) important priorities. Contributing and approaches. and partners in malaria strategy quality work to the evidence base and policy development, for disease control interventions implementation support, remains a critical focus. Uganda has the third highest malaria burden in Africa, with the disease being the cause of 50 percent of out-patient cases and 14 percent of in-patient deaths. Malaria Consortium is registered in the UK as Charity No. 1099776. WHat WE DO The Uganda programme DISEASE PREVENTION CASE managEMENT has reached almost all of Preventive activities aim to & DIagnOSTICS the more than one hundred rapidly reduce the incidence Technical assistance to the MoH districts in Uganda. of malaria and other diseases. focuses on policies and guidelines, Activities include the distribution training, supply chain management of millions of long lasting to distribute drugs and supplies, insecticidal nets through mass and diagnostic support including campaigns and routinely through the introduction of external quality health facilities, the promotion of assurance systems.
    [Show full text]
  • Integrating Neglected Tropical Diseases Into Primary Healthcare
    ADVOCACY BRIEF Untapped potential: Integrating neglected tropical diseases into primary healthcare • Mass drug administration for neglected tropical diseases (NTDs) should be accompanied by cross-sectoral complementary interventions. • Integrating NTDs with primary healthcare structures offers a sustainable approach. • This integration must be government-owned and engage a wide range of stakeholders. Background NTDs are a diverse group of 20 diseases that affect adopted by 193 countries, call for an 'end to the epidemic' more than a billion people in low and middle-income of NTDs by 2030.[8] countries[1] and disproportionately impact the most vulnerable: women, children, refugees and those living To date, global efforts to reduce the prevalence of NTDs in poverty. Collectively, they are thought to account for have largely focused on providing chemoprevention to 26.06 million disability-adjusted life years.[2] Their social at-risk populations in endemic areas through mass drug administration (MDA). While this has achieved impressive and economic impacts are also significant. Many NTDs [9] cause suffering, disability and disfigurement, which can results in breaking some disease transmission cycles and lead to social stigma,[3] exclusion and discrimination,[4] will remain key to prevention and control programmes, marginalisation of women and girls[5] and lack of there is a need for other complementary interventions as opportunities such as employment.[6] MDA: [10] In recent years, NTDs have received more attention from • is only available and recommended for five NTDs the global development community. The 2012 London • will cease to be as cost-effective as testing and treating Declaration saw decision makers endorse the World affected individuals as the prevalence of NTDs Health Organization’s (WHO) ambitious NTD roadmap[7] decreases that sought to enhance the control, prevention, and elimination of NTDs and to eradicate at least two by 2020.
    [Show full text]
  • Savings for the Poor
    Savings for the poor An example of the cost effectiveness of malaria prevention Elvanisi Nyanjura and Alice Kangume, aged two and a half and five years respectively, proudly show off their dresses which are similar to their mother’s head scarf. The girls live with their family in Bugambe sub‐county, Hoima District in the western part of Uganda. The aim of the visit is to follow up with the family regarding a mosquito net that was given to them by Azur Christian Health Center; to make sure they received it and that they were using it properly. Azur Christian Health Center is a local Community Based Organization (CBO) that was facilitated and trained by Malaria Consortium Uganda to distribute Long Lasting Insecticide treated Nets (LLINs) to children under five and pregnant women in four sub counties in Hoima District. Malaria Consortium is an international not‐for‐profit organization dedicated to the comprehensive control of malaria. Due to their close proximity to the communities, Malaria Consortium selected various CBOs to distribute nets and to build their capacity in the planning and implementation of quality net distributions on a large scale. Tereza, her husband and their three children Tereza is quick to recognize her local village Community Medicine Distributor (CMD), Kenneth, who Malaria is the leading cause of registered her household along with many others and loss of household incomes. took part in the distribution last year. Unlike other Ugandan families lose around homes where the nets were used by the head of the 25% of their income each year on household, the only net in the house covers a malaria treatment and prevention.
    [Show full text]